Fatty acid synthase as a feasible biomarker for triple negative breast cancer stem cell subpopulation cultured on electrospun scaffolds

There is no targeted therapy for triple negative breast cancer (TNBC), which presents an aggressive profile and poor prognosis. Recent studies noticed the feasibility of breast cancer stem cells (BCSCs), a small population responsible for tumor initiation and relapse, to become a novel target for TN...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabionet, Marc, Polonio-Alcalá, Emma, Relat, Joana, Yeste, Marc, Sims-Mourtada, Jennifer, Kloxin, April M., Planas, Marta, Feliu, Lidia, Ciurana, Joaquim, Puig, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606546/
https://www.ncbi.nlm.nih.gov/pubmed/34841239
http://dx.doi.org/10.1016/j.mtbio.2021.100155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606546/
https://www.ncbi.nlm.nih.gov/pubmed/34841239
http://dx.doi.org/10.1016/j.mtbio.2021.100155

Ejemplares similares